Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
about
Immune responses in patients with HIV infection after vaccination with recombinant Hepatitis B virus vaccineAntiviral drugs for viruses other than human immunodeficiency virusHepatitis B and human immunodeficiency virus co-infectionEstimation of dynamical model parameters taking into account undetectable marker valuesRapid and early virological response to chronic hepatitis C treatment with IFN 2b or PEG-IFN 2b plus ribavirin in HIV/HCV co-infected patientsTherapeutic issues in HIV/HCV-coinfected patientsEarly ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirinSeroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, TanzaniaChallenges in the treatment of HIV and HCV coinfection.Hepatitis C Virus Treatment in HIV-Coinfected Patients: No Longer Different From Monoinfection TreatmentHepatitis C treatment experiences and decision making among patients living with HIV infection.The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): early findings, 2006-2010.Seroprevalence of HBV and HIV co-infection in children and outcomes following highly active antiretroviral therapy (HAART) in Uyo, South-South NigeriaRandomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.Chronic liver disease in the Hispanic population of the United States.Similar progression of fibrosis between HIV/HCV-infected and HCV-infected patients: Analysis of paired liver biopsy samples.Sero-prevalence and factors associated with Hepatitis B and C co-infection in pregnant Nigerian women living with HIV infection.Liver transplantation in HCV/HIV positive patients.Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patientsTreatment, care and support for people co-infected with HIV and hepatitis C: a scoping review.Knockdown of autophagy-related gene LC3 enhances the sensitivity of HepG2 cells to epirubicinReliability and predictive validity of a hepatitis-related symptom inventory in HIV-infected individuals referred for Hepatitis C treatment.Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.Hepatitis infection in the treatment of opioid dependence and abuse.The influence of HAART on the efficacy and safety of pegylated interferon and ribavirin therapy for the treatment of chronic HCV infection in HIV-positive Individuals.Impact of hepatitis C on HIV progression in adults with alcohol problemsEpidemiology of HIV/AIDS in the East Azerbaijan Province, Northwest of Iran.Treatment of hepatitis C in HIV-coinfected patients.Treating viral hepatitis C: efficacy, side effects, and complications.Anti-HCV antibody among newly diagnosed HIV patients in Ughelli, a suburban area of Delta State Nigeria.Epidemiological, virological and clinical characteristics of HBV infection in 223 HIV co-infected patients: a French multi-centre collaborative study.Long-term safety of anti-TNF adalimumab in HBc antibody-positive psoriatic arthritis patients: a retrospective case series of 8 patientsAntiretroviral treatment of HIV infection: Swedish recommendations 2007.Management and treatment of hepatitis C virus in patients with HIV and hepatitis C virus coinfection: A practical guide for health care professionals.HBV and HCV seroprevalence and their correlation with CD4 cells and liver enzymes among HIV positive individuals at University of Gondar Teaching Hospital, Northwest EthiopiaHIV and Hepatitis B Virus Coinfection: Approach to Management: Case Study and Commentary.Real-World Sustained Virologic Response Rates of Sofosbuvir-Containing Regimens in Patients Coinfected With Hepatitis C and HIV.Management complexities of HIV/hepatitis C virus coinfection in the twenty-first centuryHepatitis A, B and C viral co-infections among HIV-infected adults presenting for care and treatment at Muhimbili National Hospital in Dar es Salaam, Tanzania.The role of hepatic expression of STAT1, SOCS3 and PIAS1 in the response of chronic hepatitis C patients to therapy
P2860
Q21261765-29F438CA-625D-46DE-B4DE-3EA135848470Q24635330-7053916C-EF15-4CC1-821F-275752CC75A1Q26822862-2921678E-D069-48E0-9BE4-B3A9186E7F77Q27473567-F5B1C09D-7B4B-4B41-99E2-9446B23D7B09Q27481046-1F39FC50-EDE5-46E4-AB21-AEFDB2C205BDQ27481053-DB02A9F4-57A6-46FE-92B8-6576C30EEF13Q27481147-23469A94-C718-48EB-9809-586233F064C6Q27485160-6A355B39-2583-4A71-9569-D047365A5168Q30389282-5A8C69FD-D875-4EF1-90D0-575D21085E4AQ33576161-8AE122BA-B4BB-4B66-BC1C-2DB6EA655525Q33636377-EA99903A-4AA3-467B-BADB-E4F4A0FC6135Q33726091-C0EA60B0-315C-4FB5-9ECF-09948E0F9C43Q33751609-DF8997AF-26E1-4ABB-860C-BD84680166DEQ33968358-C679A5ED-7A73-428C-92F2-CABAFC42A1C1Q34284875-7F48BC2C-13C3-485C-9468-BB328B704D09Q34380399-C77D3986-0529-4E5F-8F0E-B17081FCF40BQ34496866-910C1A68-39BD-4820-8D6E-8242710B2AEDQ34640985-2C317FA0-B434-4984-96DE-72EDDC2243BAQ34788754-D345F27A-726A-4DF5-B4A6-AA80BB04CAC8Q34954320-2886FE76-F7A3-4C54-BCE3-87F64E3C4B7EQ35159686-FE47FDA5-99B7-4530-BD56-02114A91F8ECQ35184927-5489EF24-B58E-4CD2-AD0A-86D8AF421C39Q35200808-CBFA31AC-C1F0-4993-A7F0-FB54EA4DA3EBQ35389163-F4A71B2B-A9ED-479F-B704-B358FAE4C663Q35960026-F592FFEE-6853-4A05-9786-84A3CF84237DQ36102868-279FD985-4FEA-493E-902A-9CF8010F5D2CQ36147419-AD8F7ADA-42DB-4487-97D9-676B1C2B953DQ36409500-3A1A05FC-0573-4779-BE32-CCE582616610Q36564615-AE0F9292-77E3-49EC-8D08-34D348D0F9EFQ36612792-54705B28-6617-40C5-8F82-C2DB36C5570FQ36698116-C45D6975-5095-4BF1-B995-C6AECE1933BFQ36757744-2DBDAAC7-E32F-428B-A7D8-3FDC022EFB5DQ36852859-BBD47CC1-929A-495F-B094-D746F6C12A1FQ36871125-24DEEFCA-C6DD-49E9-A9FF-A251C3B16989Q36895257-271AC58A-330C-4C7A-9322-917BAAABA307Q36916860-C1A8E572-41ED-4B93-855C-EBF36FB81F00Q36948099-D4BD457D-3ACB-4AB0-8119-616803C06529Q36995854-BB1604DF-E0B7-4324-95B3-1CD1184AA120Q37059321-CBB962AC-3DBD-4305-A6C6-4BE6E9D12BFDQ37063664-3A780AA2-7D14-48B0-ACD1-2D96C2F6CCB1
P2860
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Short statement of the first E ...... C in HIV co-infected patients.
@ast
Short statement of the first E ...... C in HIV co-infected patients.
@en
type
label
Short statement of the first E ...... C in HIV co-infected patients.
@ast
Short statement of the first E ...... C in HIV co-infected patients.
@en
prefLabel
Short statement of the first E ...... C in HIV co-infected patients.
@ast
Short statement of the first E ...... C in HIV co-infected patients.
@en
P2093
P50
P1476
Short statement of the first E ...... C in HIV co-infected patients.
@en
P2093
Nathan Clumeck
Peter Reiss
Wolfram Gerlich
Yazdan Yazdanpanah
P304
P356
10.1016/J.JHEP.2005.03.003
P50
P577
2005-05-01T00:00:00Z